Chemoinformaics analysis of 28-HYDROXY-OCTACOSANOIC-ACID
| Molecular Weight | 440.753 | nRot | 27 |
| Heavy Atom Molecular Weight | 384.305 | nRig | 1 |
| Exact Molecular Weight | 440.423 | nRing | 0 |
| Solubility: LogS | -5.822 | nHRing | 0 |
| Solubility: LogP | 10.263 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 87 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 86.5064 |
| nHD | 2 | BPOL | 57.0476 |
| QED | 0.125 |
| Synth | 1.722 |
| Natural Product Likeliness | 0.316 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -5.274 |
| MDCK | 0.00000597 |
| BBB | 0.004 |
| PPB | 0.977121 |
| VDSS | 1.458 |
| FU | 0.00625411 |
| CYP1A2-inh | 0.072 |
| CYP1A2-sub | 0.131 |
| CYP2c19-inh | 0.114 |
| CYP2c19-sub | 0.041 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.996 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.014 |
| CYP3a4-inh | 0.061 |
| CYP3a4-sub | 0.004 |
| CL | 3.315 |
| T12 | 0.19 |
| hERG | 0.236 |
| Ames | 0.004 |
| ROA | 0.006 |
| SkinSen | 0.968 |
| Carcinogencity | 0.028 |
| EI | 0.908 |
| Respiratory | 0.823 |
| NR-Aromatase | 0.163 |
| Antiviral | No |
| Prediction | 0.615693 |